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OBJECTIVES: To assess health care resource utilization (HRU) and costs asso-
ciated with comorbid obesity in patients with type 2 diabetes mellitus (T2DM) 
from a nationally representative US sample. METHODS: The 2009 Medical 
Expenditure Panel Survey was analyzed to identify adults (≥20 years) with 
diabetes (ICD-9-CM: 250). T2DM was identified if one of the following criteria was 
met: 1) evidence of ≥1 oral or non-insulin injectable anti-diabetic medication; 2) 
diagnosis of diabetes after age 30; 3) diagnosis before age 30 and not on insulin 
monotherapy. Pregnant women were excluded. Annual HRU and costs were 
compared for individuals with T2DM based on the presence of comorbid obesity 
(BMI≥30 kg/m2). A generalized linear regression model adjusting for patient 
demographic and clinical characteristics was performed to assess the association 
between comorbid obesity and total health care costs. Population weights were 
applied to account for the multi-stage sampling design to produce nationally 
representative estimates. RESULTS: Of the 2,269 T2DM patients (representing 
19.2 million individuals in the US), 54.5% were obese. Obese T2DM patients were 
more likely to be younger (59 vs. 65 years; p<0.01) than non-obese T2DM patients. 
Obese T2DM patients had similar inpatient hospital (17.8% vs. 17.9%; p=0.99) and 
emergency room (21.7% vs. 19.5%; p=0.33) utilization but utilized more outpatient 
hospital visits (33.3% vs. 27.9%; p=0.03), had more prescription medication fills 
(48.0 vs. 37.1, p<0.01) and higher total health care costs ($12,009 vs. $10,081, 
p=0.02) than non-obese T2DM patients. After controlling for age, gender, race, 
income, insured status and comorbidities, obese T2DM patients had total health 
care costs of 1.19 times those of the non-obese T2DM patients (p=0.04). 
CONCLUSIONS: Obesity appears to be associated with higher health care costs in 
T2DM patients. Effective weight management in T2DM patients may be cost-
effective and should be considered in diabetes treatment plans.  
 
PHS99  
TO IDENTIFY COMORBID DEPRESSION IN DIABETES PATIENTS AND 
COMPARING THE DIFFERENCES IN USE OF HEALTH CARE SERVICES IN 
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OBJECTIVES: To assess the effect of comorbid depression on rates of health care 
resource utilization in patients with diabetes. METHODS: We carried out a 
secondary analysis of data from 2008 Medical Expenditure Panel Survey for the 
year. In contrast to previous research, we identified diabetes and comorbid 
depression among the adult population by using their self-report. People with 
diabetes were identified by examining their self report regarding a diabetes 
diagnosis. We identified patients with diagnosed and undiagnosed depression by 
using a score of ≥3 on the two-item Patient Health Questionnaire. This unique 
method of identifying depression has been validated elsewhere. We calculated 
odds ratios for having depression in respondents with and without diabetes 
adjusting for demographic factors. We compared the mean unadjusted health 
care utilization rates in the diabetic people with and without depression. We also 
assessed the factors that were associated with incidence of comorbid diabetes 
and the use of health care services. RESULTS: In the year 2008, 2381 respon-
dents suffered from diabetes while 400 respondents suffered from comorbid 
depression. Diabetics were more likely than non-diabetics to suffer from 
depression (Adjusted OR 1.20, 95% CI 1.05–1.37). People suffering from this 
comorbidity were more likely to be females, married, Hispanic and have a lower 
poor income level. The mean emergency room visits (0.90 vs. 0.41 p<0.001), the 
mean outpatient visits (19.62 vs. 16.22 p<0.001) and the mean office based visits 
(215.1 vs. 159.3 p=0.003) were higher in diabetic patients with depression. In the 
adjusted analyses, depression was associated with an increase in the use of 
health care resources. CONCLUSIONS: Utilizing a unique way to identify diabetes 
and depression in the general population, we found that the likelihood of 
suffering from depression is higher in case of diabetics. Comorbid diabetes and 
depression is associated with higher use of health services.  
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REDUCING TOTAL HEALTH CARE COSTS BY SHIFTING TO OUTPATIENT (OP) 
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OBJECTIVES: Rising health care costs and financial penalties have necessitated 
treatment strategies for ABSSSI that avoid hospital admissions and reduce 
length of stay (LOS), hospital acquired infections (HAIs), and readmissions. 
Providing parenteral antibiotic therapy in OP settings provides an opportunity to 
shift care outside the hospital to free hospital beds and reduce additional LOS 
from HAIs. This analysis estimated, from a US payer perspective, cost offsets of 
treating gram+ ABSSSIs with varied hospital LOS followed by OP care. METHODS: 
Economic drivers of care were estimated using a literature-based economic 
model incorporating inpatient (IP) and OP components. The model incorporated 
equal efficacy, adverse events (AE), resource use, and costs from literature and 
public sources. Once and twice daily OP infusions to achieve a 14-day treatment 
were tested to determine cost offsets shifting IP days to OP days. Sensitivity 
analyses were performed. Costs were adjusted to 2012US$. RESULTS: Total non-
drug medical cost for ABSSSI ranged from $8,790-$15,968 for 3 and 7 days IP, 
respectively, while treatment entirely OP to avoid admission ranged from $3692-
$4353. IP medical costs included IP bed-day ($1853) and AE costs ($343). OP care 
included either daily home care ($194) or infusion center fee ($154), PICC line 
with fluoroscopy ($786), PICC complications ($188), labs ($102), and physician 
visit ($222) for evaluation of ABSSSI. IP versus OP cost breakdown was: 3 days IP 
($5,902)/11 days OP ($2,888-$3,429); 7 days IP ($13,314)/7 days OP ($2,273-$2,654). 
Sensitivity analyses revealed OP cost drivers to be IV days, infusion/OP care 
costs, and PICC costs versus LOS, bed-day cost, and IV days for IP drivers. 
CONCLUSIONS: Shifting ABSSSI care to OP settings may result in cost savings up 
to 44%, with potential to prevent HAIs. Typical OP scenarios represent ~33% of 
total medical cost, with PICC accounting for 28-43% of OP burden. Value of new 
ABSSSI therapies will be driven by eliminating need for PICC line and ability to 
reduce/avoid hospital days.  
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Due to the market turbulence facing the hospital industry, the financial viability 
of teaching hospitals has been severely threatened. Their missions of education, 
research, and patient care even strengthen this crisis. Therefore, the objective of 
this study is to conduct a comparative analysis of the cost, volume, and profit 
(CVP) structure between large nonprofit urban teaching hospitals and small for-
profit rural/suburban non-teaching hospitals. The following two hypotheses 
were developed: 1) large nonprofit urban teaching hospitals tend to have higher 
fixed cost, lower variable cost, lower total revenue adjusted by case mix index 
(CMI), and lower return on total assets (ROA), and 2) small for-profit 
rural/suburban non-teaching hospitals tend to have lower fixed cost, higher 
variable cost, higher total revenue adjusted by CMI, and higher ROA. Using 117 
teaching hospitals and 102 non-teaching hospitals selected from the Medicare 
Cost Report database in 2005, the results from multiple regression indicated that 
large nonprofit teaching hospitals located in urban areas are more likely to have 
higher fixed cost and lower variable cost. While such cost structure doesn’t 
necessarily affect their total revenue adjusted by CMI, it does lead to a lower 
return on hospitals’ total assets. The results support our hypotheses in terms of 
fixed cost percentage, variable cost percentage, and ROA, but not total revenue 
adjusted by CMI. The results suggest that cost structure is significantly 
associated with hospitals’ performance. Also, as teaching hospitals’ portfolios of 
services and programs increase (e.g., provision of uncompensated care to 
Medicare and Medicaid patients and doing research), it becomes strategically 
necessary and critical to manage the allocation of resources or investments into 
the fixed capital that supports the business.  
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OBJECTIVES: The BI.2IM Project started in 2010 to improve costs control and 
register resource utilization of several Brazilian HMOs based on an already 
established (2007) administrative database. The project has evolved in 2011 for 
another utilization related to payment for performance (P4P) and evaluation of 
standard of resource utilization (in-hospital and medical office based data), 
allowing to follow identified patients over prolonged periods of time and to study 
the quantity and cost of health care services provided. Therefore, this 5 million 
lives database (BI.2iM) probabily allows retrospective health care resource 
utilization studies based upon the registered data and their related costs. The 
aim of this study is to verify if BI.2iM database is statistically comparable with 
the total Brazilian Private Healthcare population in terms of regional 
distribuition, gender and age. METHODS: The sample quantity of patients was 
statistically compared with the total private market population in terms of 
regional distribution and gender. Other available information was accessed and 
compared too. RESULTS: The sample compares well to the national private 
market population (sample error of 0,044%) as well as in terms of regional 
distribution. The BI.2iM database can be searched by ICD10 code, Brazilian codes 
for procedures and tests and allows follow up of the patient’s treatment. 
CONCLUSIONS: The BI.2iM sample constitutes a well-characterized supple-
mentary health study population statistically comparable to the national private 
market population. Its results extrapolated to the total supplementary health 
care together with the public health care database (DATASUS) may enable 
evaluation the total Brazilian Healthcare market.  
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OBJECTIVES: To characterize the outpatient visits for schizophrenia in the 
United States in comparison to major depressive disorder (MDD) and general 
outpatient (GOP) visits. METHODS: The National Ambulatory Care Survey 
(NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS) data 
from 2003 to 2010 were pooled and weighted to provide national level estimates. 
Using ICD-9 codes, visits were classified as schizophrenia (295.xx) or MDD 
(296.2x-296.3x) visits; all others were classified as GOP visits. Estimation methods 
accounting for the surveys’ multistage sampling procedures provided percent-
